Since our founding in 2010, CGT Global has pursued our mission to transform healthcare as we accelerate cell and gene therapy research and clinical trials, streamline the commercialization of new treatments, and map the last mile to patient access to these life-changing remedies. By innovating each stage in the cycle; development, commercialization, and delivery, we reduce the overall cost of the care and multiply access points so that millions can receive cutting edge, life-saving gene and cell therapies.

Description
Plasma is the fluid portion of the blood that allows the transport of leukocytes (lymphocytes, monocytes, dendritic cells, and granulocytes), platelets, and red blood cells to or from the tissues of the body. Plasma helps maintain blood pressure and regulates body temperature. It is composed of proteins, inorganic salts, nutrients, gases, waste material from cells, and various hormones and enzymes.
Plasma is either fractionated from whole blood bags by centrifugation or collected on the Spectra Optia® Apheresis System and stored at -80°C. The harvested plasma will contain a reduced platelet count.
Collected from IRB consented donors.
Additional information
Anticoagulant | |
---|---|
Format | |
Grade | |
Species | |
Cell and Tissue Source | |
Disease State | |
Donor Attributes |
1 Yucel et al. (2019) Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients. Transplantation 103(12): 2657-2665.